These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 179130)

  • 21. [Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies].
    Fujii H; Shimizu T; Seki S; Isemura T; Yamamoto K; Kanoh T; Ohno Y
    Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):622-32. PubMed ID: 6814143
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heavy chain disease: humoral and cellular findings in six patients with mu chain disease (author's transl)].
    Wetter O; Schmidt CG; Linder KH; Leene W
    J Cancer Res Clin Oncol; 1979 Jun; 94(2):207-23. PubMed ID: 112103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Spleen irradiation and B/T cell relationship in chronic lymphocytic leukaemia.
    Astaldi G; Astaldi GC; iVettori PP; Astaldi A
    Lancet; 1975 Mar; 1(7905):529-30. PubMed ID: 47006
    [No Abstract]   [Full Text] [Related]  

  • 24. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneously increased expression of the c-myc and mu chain genes in the acute blastic transformation of a chronic lymphocytic leukaemia.
    Torelli UL; Torelli GM; Emilia G; Selleri L; Venturelli D; Artusi T; Donelli A; Colò A; Fornieri C
    Br J Haematol; 1987 Feb; 65(2):165-70. PubMed ID: 3103669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosynthesis and characterisation of IgMlambda in a case of chronic lymphocytic leukaemia with intracellular immunoglobulin inclusions.
    Roberts GH; Gordon J; Smith JL; Newell D; Pike R
    J Clin Pathol; 1979 Mar; 32(3):272-9. PubMed ID: 107201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytosis in a patient with malignant fibrous histiocytoma.
    Taylor HG; Terebelo HR; Gamez A
    Cancer; 1982 Oct; 50(8):1563-7. PubMed ID: 6288217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin structure, synthesis, secretion, and relation to neoplasms of B cells.
    Franklin EC; Buxbaum J
    Clin Haematol; 1977 Jun; 6(2):503-32. PubMed ID: 410572
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.
    Feremans W; Caudron M; Bieva C
    J Clin Pathol; 1979 Apr; 32(4):334-43. PubMed ID: 109474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell markers on lymphoblasts in acute lymphoblastic leukaemia.
    Gajl-Peczalska KJ; Bloomfield CD; Nesbit ME; Kersey JH
    Clin Exp Immunol; 1974 Aug; 17(4):561-9. PubMed ID: 4219600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of a receptor for IgM (muFcR) on haemic cells.
    Burns GF; Cawley JC; Worman CP; Barker CR; Hayhoe FG
    Am J Hematol; 1979; 6(3):243-51. PubMed ID: 114046
    [No Abstract]   [Full Text] [Related]  

  • 32. Mu-heavy chain disease: presentation as a benign monoclonal gammopathy.
    Wahner-Roedler DL; Kyle RA
    Am J Hematol; 1992 May; 40(1):56-60. PubMed ID: 1566748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mu heavy-chain disease--a defect in immunoglobulin assembly. Structural studies of the kappa chain.
    Frangione B; Franklin EC; Prelli F
    Scand J Immunol; 1976; 5(6-7):623-7. PubMed ID: 824712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual T cells in chronic lymphocytic leukaemia.
    Goldstone AH; Kerr L; Urbaniak SJ; Farmer A; Irvine WJ
    Lancet; 1973 Mar; 1(7801):481-2. PubMed ID: 4120388
    [No Abstract]   [Full Text] [Related]  

  • 35. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia.
    Catovsky D; Lauria F; Matutes E; Foa R; Mantovani V; Tura S; Galton DA
    Br J Haematol; 1981 Apr; 47(4):539-44. PubMed ID: 6971120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of T-cells in chronic lymphocytic leukaemia.
    Catovsky D; Miliani E; Okos A; Galton DA
    Lancet; 1974 Sep; 2(7883):751-2. PubMed ID: 4143015
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrophoresis of lymphocytes from normal human subjects and patients with chronic lymphocytic leukaemia.
    Goldstone AH; Urbaniak SJ; Irvine WJ
    Clin Exp Immunol; 1974 May; 17(1):113-20. PubMed ID: 4549566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heavy chain diseases (author's transl)].
    Dammacco F; Triggiani M
    Haematologica; 1979 Oct; 64 Suppl():44-9. PubMed ID: 120283
    [No Abstract]   [Full Text] [Related]  

  • 39. Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia.
    Platsoucas CD; Kempin S; Karanas A; Clarkson B; Good RA; Gupta S
    Clin Exp Immunol; 1980 May; 40(2):256-63. PubMed ID: 6159999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal origin of B cells producing k, lambda and k lambda immunoglobulin light chains in a patient with chronic lymphocytic leukemia.
    del Senno L; Gandini D; Gambari R; Lanza F; Tomasi P; Castoldi G
    Leuk Res; 1987; 11(12):1093-8. PubMed ID: 2826930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.